230 related articles for article (PubMed ID: 23063548)
1. Magnetic targeting of nanoparticles across the intact blood-brain barrier.
Kong SD; Lee J; Ramachandran S; Eliceiri BP; Shubayev VI; Lal R; Jin S
J Control Release; 2012 Nov; 164(1):49-57. PubMed ID: 23063548
[TBL] [Abstract][Full Text] [Related]
2. Enhanced blood-brain barrier transmigration using a novel transferrin embedded fluorescent magneto-liposome nanoformulation.
Ding H; Sagar V; Agudelo M; Pilakka-Kanthikeel S; Atluri VS; Raymond A; Samikkannu T; Nair MP
Nanotechnology; 2014 Feb; 25(5):055101. PubMed ID: 24406534
[TBL] [Abstract][Full Text] [Related]
3. Movement of magnetic nanoparticles in brain tissue: mechanisms and impact on normal neuronal function.
Ramaswamy B; Kulkarni SD; Villar PS; Smith RS; Eberly C; Araneda RC; Depireux DA; Shapiro B
Nanomedicine; 2015 Oct; 11(7):1821-9. PubMed ID: 26115639
[TBL] [Abstract][Full Text] [Related]
4. Guidance of Magnetic Nanocontainers for Treating Alzheimer's Disease Using an Electromagnetic, Targeted Drug-Delivery Actuator.
Do TD; Ul Amin F; Noh Y; Kim MO; Yoon J
J Biomed Nanotechnol; 2016 Mar; 12(3):569-74. PubMed ID: 27280254
[TBL] [Abstract][Full Text] [Related]
5. The transport of non-surfactant based paclitaxel loaded magnetic nanoparticles across the blood brain barrier in a rat model.
Dilnawaz F; Singh A; Mewar S; Sharma U; Jagannathan NR; Sahoo SK
Biomaterials; 2012 Apr; 33(10):2936-51. PubMed ID: 22264522
[TBL] [Abstract][Full Text] [Related]
6. Transmigration of magnetite nanoparticles across the blood-brain barrier in a rodent model: influence of external and alternating magnetic fields.
Gupta R; Chauhan A; Kaur T; Kuanr BK; Sharma D
Nanoscale; 2022 Dec; 14(47):17589-17606. PubMed ID: 36409463
[TBL] [Abstract][Full Text] [Related]
7. Targeted drug delivery to the brain using magnetic nanoparticles.
Thomsen LB; Thomsen MS; Moos T
Ther Deliv; 2015; 6(10):1145-55. PubMed ID: 26446407
[TBL] [Abstract][Full Text] [Related]
8. Study of amphotericin B magnetic liposomes for brain targeting.
Zhao M; Hu J; Zhang L; Zhang L; Sun Y; Ma N; Chen X; Gao Z
Int J Pharm; 2014 Nov; 475(1-2):9-16. PubMed ID: 25151436
[TBL] [Abstract][Full Text] [Related]
9. Simulation of magnetic nanoparticles crossing through a simplified blood-brain barrier model for Glioblastoma multiforme treatment.
Gkountas AA; Polychronopoulos ND; Sofiadis GN; Karvelas EG; Spyrou LA; Sarris IE
Comput Methods Programs Biomed; 2021 Nov; 212():106477. PubMed ID: 34736172
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic parameters and tissue distribution of magnetic Fe(3)O(4) nanoparticles in mice.
Wang J; Chen Y; Chen B; Ding J; Xia G; Gao C; Cheng J; Jin N; Zhou Y; Li X; Tang M; Wang XM
Int J Nanomedicine; 2010 Oct; 5():861-6. PubMed ID: 21042548
[TBL] [Abstract][Full Text] [Related]
11. Targeting intracellular compartments by magnetic polymeric nanoparticles.
Kocbek P; Kralj S; Kreft ME; Kristl J
Eur J Pharm Sci; 2013 Sep; 50(1):130-8. PubMed ID: 23603023
[TBL] [Abstract][Full Text] [Related]
12. Influence of chitosan coating on magnetic nanoparticles in endothelial cells and acute tissue biodistribution.
Agotegaray M; Campelo A; Zysler R; Gumilar F; Bras C; Minetti A; Massheimer V; Lassalle V
J Biomater Sci Polym Ed; 2016 Aug; 27(11):1069-85. PubMed ID: 27251857
[TBL] [Abstract][Full Text] [Related]
13. Blood-brain barrier crossing using magnetic stimulated nanoparticles.
Chen J; Yuan M; Madison CA; Eitan S; Wang Y
J Control Release; 2022 May; 345():557-571. PubMed ID: 35276300
[TBL] [Abstract][Full Text] [Related]
14. Surfactants, not size or zeta-potential influence blood-brain barrier passage of polymeric nanoparticles.
Voigt N; Henrich-Noack P; Kockentiedt S; Hintz W; Tomas J; Sabel BA
Eur J Pharm Biopharm; 2014 May; 87(1):19-29. PubMed ID: 24607790
[TBL] [Abstract][Full Text] [Related]
15. Magnetic Nanoparticles in the Central Nervous System: Targeting Principles, Applications and Safety Issues.
D'Agata F; Ruffinatti FA; Boschi S; Stura I; Rainero I; Abollino O; Cavalli R; Guiot C
Molecules; 2017 Dec; 23(1):. PubMed ID: 29267188
[TBL] [Abstract][Full Text] [Related]
16. Targeted brain derived neurotropic factors (BDNF) delivery across the blood-brain barrier for neuro-protection using magnetic nano carriers: an in-vitro study.
Pilakka-Kanthikeel S; Atluri VS; Sagar V; Saxena SK; Nair M
PLoS One; 2013; 8(4):e62241. PubMed ID: 23653680
[TBL] [Abstract][Full Text] [Related]
17. Optimizing superparamagnetic iron oxide nanoparticles as drug carriers using an in vitro blood-brain barrier model.
Shi D; Mi G; Bhattacharya S; Nayar S; Webster TJ
Int J Nanomedicine; 2016; 11():5371-5379. PubMed ID: 27799764
[TBL] [Abstract][Full Text] [Related]
18. A Basic ApoE-Based Peptide Mediator to Deliver Proteins across the Blood-Brain Barrier: Long-Term Efficacy, Toxicity, and Mechanism.
Meng Y; Wiseman JA; Nemtsova Y; Moore DF; Guevarra J; Reuhl K; Banks WA; Daneman R; Sleat DE; Lobel P
Mol Ther; 2017 Jul; 25(7):1531-1543. PubMed ID: 28456380
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle-mediated delivery of oligonucleotides to the blood-brain barrier: in vitro and in situ brain perfusion studies on the uptake mechanisms.
Ko YT
J Drug Target; 2013 Nov; 21(9):866-73. PubMed ID: 23952765
[TBL] [Abstract][Full Text] [Related]
20. Feasibility Study of the Permeability and Uptake of Mesoporous Silica Nanoparticles across the Blood-Brain Barrier.
Baghirov H; Karaman D; Viitala T; Duchanoy A; Lou YR; Mamaeva V; Pryazhnikov E; Khiroug L; de Lange Davies C; Sahlgren C; Rosenholm JM
PLoS One; 2016; 11(8):e0160705. PubMed ID: 27547955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
